Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Current Vascular Pharmacology|May 31, 2017
Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up StudyMagdalena Dusejovska, Barbora Stankova, Marek Vecka, et al.
Neuro Endocrinology Letters|November 28, 2012
Plasma fatty acid profile in depressive disorder resembles insulin resistance stateTomas Vareka, Marek Vecka, Roman Jirak, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 27, 2015
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?Miroslav Zeman, Marek Vecka, František Perlík, et al.
Neuro Endocrinology Letters|November 28, 2012
N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemiaMarek Vecka, Magdalena Dušejovská, Barbora Stankova, et al.
Casopis Lekaru Ceskych|April 19, 2016
[Desaturases of fatty acids (FADS) and their physiological and clinical implication]Aleš Žák, Adolf Slabý, Eva Tvrzická, et al.
Metabolites|June 23, 2022
FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic SyndromeAleš Žák, Marie Jáchymová, Michal Burda, et al.
The Journal of Nutritional Biochemistry|February 19, 2008
The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stressAles Zák, Marie Jáchymová, Eva Tvrzická, et al.
Nutrition and Cancer|October 16, 2012
Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parametersJaroslav Macášek, Marek Vecka, Aleš Žák, et al.
Pageof 6